Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research

EuroIntervention

Volumn 5, Issue 1, 2009, Pages 140-148

  Granada, Juan F ^a   Kaluza, Greg L ^a   Wilensky, Robert L ^b   Biedermann, Barbara C ^c   Schwartz, Robert S ^d   Falk, Erling ^e  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c University Hospital Bruderholz   (Switzerland)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angiogenesis; Complex lesions; Coronary artery disease; Imaging; Plaque rupture

Indexed keywords

ANIMAL MODEL; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NONHUMAN; REVIEW; SWINE; VALIDATION PROCESS;

EID: 70749126623     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: 10.4244/EIJV5I1A22     Document Type: Review

References (59)

1. Rekhter MD. How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res. 2002;54(1):36-41.
2. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002;106(14):1867-1873.
3. Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, Waksman R, Machan L, Weinberger J, Wilensky RL, Goode JL, Hottenstein OD, Zuckerman BD, Virmani R. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation. 2004;110(16):2498-2505.
4. Granada JF, Kaluza GL, Raizner AE, Moreno PR. Vulnerable plaque paradigm: prediction of future clinical events based on a morphological definition. Catheter Cardiovasc Interv. 2004;62(3):364-374.
5. Wernersson R, Schierup MH, Jorgensen FG, Gorodkin J, Panitz F, Staerfeldt HH, Christensen OF, Mailund T, Hornshoj H, Klein A, Wang J, Liu B, Hu S, Dong W, Li W, Wong GK, Yu J, Bendixen C, Fredholm M, Brunak S, Yang H, Bolund L. Pigs in sequence space: a 0.66X coverage pig genome survey based on shotgun sequencing. BMC Genomics. 2005;6(1):70.
6. Schook L, Beattie C, Beever J, Donovan S, Jamison R, ZuckermannF, Niemi S, Rothschild M, Rutherford M, Smith D. Swine in biomedical research: creating the building blocks of animal models. Anim Biotechnol. 2005;16(2):183-190.
7. Swindle MM, Horneffer PJ, Gardner TJ, Gott VL, Hall TS, Stuart RS, Baumgartner WA, Borkon AM, Galloway E, Reitz BA. Anatomic and anesthetic considerations in experimental cardiopulmonary surgery in swine. Lab Anim Sci. 1986;36(4):357-361.
8. Smith AC, Spinale FG, Swindle MM. Cardiac function and morphology of Hanford miniature swine and Yucatan miniature and micro swine. Lab Anim Sci. 1990;40(1):47-50.
9. White FC, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992;71(6):1490-1500.
10. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004;110(18):2843-2850.
11. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7-12.
12. Lee KT, Kim DN, Thomas WA. Atherosclerosis in Swine. In: Stanton HC, Mersmann HJ, eds. Swine in Cardiovascular Research. Boca Raton, FL: CRC; 1986:33-48.
13. Reitman JS, Mahley RW, Fry DL. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis. 1982;43(1):119-132.
14. Thorpe PE, Hunter WJ, 3rd, Zhan XX, Dovgan PS, Agrawal DK. Anoninjury, diet-induced swine model of atherosclerosis for cardiovascular-interventional research. Angiology. 1996;47(9):849-857.
15. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, Rapacz J. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet. 1998;76(5):379-386.
16. Prescott MF, McBride CH, Hasler-Rapacz J, Von Linden J, Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol. 1991;139(1):139-147.
17. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001;50(7):1654-1665.
18. Mohler ER, 3rd, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, Hallman T, Steplewski K, Gertz Z, Lu MM, Wilensky RL. Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature. Arterioscler Thromb Vasc Biol. 2008;28(5):850-855.
19. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007;49(25):2379-2393.
20. Wilensky RL, Shi Y, Mohler ER, III, Hamamdzic D, Burgert ME, Li JU, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelcovitz D, Yang J, Webb C, Zhang L, Zhang P, Gel b MH, Walker MC, Zalewski A, Macphee CH. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008; 14:1059-1068.
21. Wang YX, Fitch R, Li W, Werner M, Halks-Miller M, Lillis B, Vergona R, Post J, Sullivan ME, Verhallen PF. Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis. Vascul Pharmacol. 2002;39(1-2): 69-76.
22. Barbeau ML, Klemp KF, Guyton JR, Rogers KA. Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17(4):688-694.
23. Carter AJ, Bailey L, Devries J, Hubbard B. The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosis. Coron Artery Dis. 2000;11(6):473-479.
24. de Smet BJ, van der Zande J, van der Helm YJ, Kuntz RE, Borst C, Post MJ. The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. Cardiovasc Res. 1998;39(1):224-232.
25. Gal D, Rongione AJ, Slovenkai GA, DeJesus ST, Lucas A, Fields CD, Isner JM. Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions. Am Heart J. 1990;119(2 Pt 1):291-300.
26. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med. 2006;56(1):35-45.
27. Lee KT, Jarmolych J, Kim DN, Grant C, Krasney JA, Thomas WA, Bruno AM. Production of advanced coronary atherosclerosis, myocardial infarction and "sudden death" in swine. Exp Mol Pathol. 1971; 15(2):170-190.
28. Mihaylov D, van Luyn MJ, Rakhorst G. Development of an animal model of selective coronary atherosclerosis. Coron Artery Dis. 2000;11(2):145-149.
29. Koktzoglou I, Harris KR, Tang R, Kane BJ, Misselwitz B, Weinmann HJ, Lu B, Nagaraj A, Roth SI, Carroll TJ, McPherson DD, Li D. Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine. Invest Radiol. 2006;41(3):299-304.
30. Ishii A, Vinuela F, Murayama Y, Yuki I, Nien YL, Yeh DT, Vinters HV. Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia. AJNR Am J Neuroradiol. 2006;27(9):1893-1899.
31. Keelan P, Bayes-Genis A, Kantor B, Singh R, Carlson P, Lewis D, Schwartz RS. A novel porcine model for in vivo detection of vulnerable plaque: deposition and localization of lipid-rich lesions in the coronary arterial wall [abstract]. Circulation. 2001;104:II-67.
32. Granada JF, Moreno PR, Burke AP, Schulz DG, Raizner AE, Kaluza GL. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis. 2005;16(4):217-224.
33. Granada JF, Wallace-Bradley D, Win HK, Alviar CL, Builes A, Lev EI, Barrios R, Schulz DG, Raizner AE, Kaluza GL. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol. 2007;27(2):387-393.
34. Tellez A, Alviar C, Builes A, Lopez-Berestein G, Sanguino A, Wallace-Bradley D, Ballantyne C, Perrard X, Schulz D, Kleiman N, Lev E, Frangogiannis N, Kaluza G, Granada J. Pro-Inflammatory Chemokines are Expressed in the Pig Model of Complex Coronary Lesions Induced by Intramural Injection of Lipids (TCT E-Abstract 603). Am J Cardiol. Oct 2007;100 (suppl):232L.
35. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation. 1990;82(6):2190-2200.
36. Lin W, Abendschein DR, Celik A, Dolan RP, Lauffer RB, Walovitch RC, Haacke EM. Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs. J Magn Reson Imaging. 1997;7(6):963-971.
37. Spuentrup E, Ruebben A, Mahnken A, Stuber M, Kolker C, Nguyen TH, Gunther RW, Buecker A. Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent. Circulation. 2005;111(8):1019-1026.
38. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate- pharmacokinetic analysis and experimental porcine model. Radiology. 1998;206(2):455-464.
39. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology. 1998;207(3):657-662.
40. Bae KT, Tran HQ, Heiken JP. Multiphasic injection method for uniform prolonged vascular enhancement at CT angiography: pharmacokinetic analysis and experimental porcine model. Radiology. 2000;216(3):872-880.
41. Rist C, Nikolaou K, Flohr T, Wintersperger BJ, Reiser MF, Becker CR. High-resolution ex vivo imaging of coronary artery stents using 64-slice computed tomography--initial experience. Eur Radiol. 2006;16(7):1564-1569.
42. D'Arceuil HE, de Crespigny AJ, Pelc L, Howard D, Alley M, Seri S, Hashiguchi Y, Nakatani A, Moseley ME. An MRA study of vascular stenosis in a pig model using CH3-DTPA-Gd (NMS60) and Gd-DTPA. Magn Reson Imaging. 2004;22(9):1243- 1248.
43. Green JD, Omary RA, Schirf BE, Tang R, Lu B, Gehl JA, Huang JJ, Carr JC, Pereles FS, Li D. Comparison of X-ray fluoroscopy and interventional magnetic resonance imaging for the assessment of coronary artery stenoses in swine. Magn Reson Med. 2005;54(5):1094-1099.
44. McFalls EO, Ward H, Fashingbauer P, Gimmestad G, Palmer B. Myocardial blood flow and FDG retention in acutely stunned porcine myocardium. J Nucl Med. 1995;36(4):637-643.
45. Chareonthaitawee P, Schaefers K, Baker CS, Turkheimer F, Stegger L, Banner NR, Yacoub M, Bonser RS, Iozzo P, Camici PG, Rimoldi O. Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging. 2002;29(2):203-215.
46. Schafers KP, Spinks TJ, Camici PG, Bloomfield PM, Rhodes CG, Law MP, Baker CS, Rimoldi O. Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation. J Nucl Med. 2002;43(8):1031-1040.
47. Wagner B, Anton M, Nekolla SG, Reder S, Henke J, Seidl S, Hegenloh R, Miyagawa M, Haubner R, Schwaiger M, Bengel FM. Noninvasive characterization of myocardial molecular interventions by integrated positron emission tomography and computed tomography. J Am Coll Cardiol. 2006;48(10):2107-2115.
48. Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, Ritman EL, Gibbons RJ. Reproducibility of measurements of regional myocardial blood flow in a model of coronary artery disease: Comparison of H215O and 13NH3 PET techniques. J Nucl Med. 2006;47(7):1193-1201.
49. Hartvig P, Waldenstrom A, Wikstrom G, Zielinski T, Martinussen HJ, Carslsten J, Voipio-Pulkki LM, Lundqvist H, Bjurling P, Nagren K, et al. The diabetic heart: a porcine model evaluated with positron emission tomography using 1-11C-palmitate and 3-11C-pyruvate. Diabetes Res. 1989;12(1):1-5.
50. Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med. 2005;46(7):1186-1193.
51. Vallabhajosula S, Granada JF, Kothari PJ. Molecular Imaging of Vulnerable Plaque: Comparison of 3 PET Tracers; [11C]PK11195, [18F]Fluorocholine and [18F]FDG in a Porcine Model of Complex Coronary Atherosclerosis. (Abstract). J Nucl Med. 2007;48:103p.
52. Mehran R, Mintz GS, Hong MK, Tio FO, Bramwell O, Brahimi A, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB. Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardiol. 1998;32(3):794-799.
53. Asawa K, Kataoka T, Kobayashi Y, Hasegawa T, Nishioka H, Yamashita H, Qiu Z, Ehara S, Hirose M, Kamimori K, Shimada K, Yoshiyama M, Yoshikawa J. Method analysis for optimal continuous imaging using intravascular optical coherence tomography. J Cardiol. 2006;47(3):133-141.
54. Tearney GJ, Jang IK, Kang DH, Aretz HT, Houser SL, Brady TJ, Schlendorf K, Shishkov M, Bouma BE. Porcine coronary imaging in vivo by optical coherence tomography. Acta Cardiol. 2000;55(4):233-237.
55. Maeng M, Olesen PG, Emmertsen NC, Thorwest M, Nielsen TT, Kristensen BO, Falk E, Andersen HR. Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron Artery Dis. 2001;12(4):285-293.
56. de Korte CL, van der Steen AF. Intravascular ultrasound elastography: an overview. Ultrasonics. 2002;40(1-8):859-865.
57. Hamilton AJ, Huang SL, Warnick D, Rabbat M, Kane B, Nagaraj A, Klegerman M, McPherson DD. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43(3):453-460.
58. Frohlich G, Strehblow C, Sperker W, Yahya N, Shirazi M, Hevesi A, Garamvolgyi R, Hadjiev J, Scherzer T, Glogar D, Gyongyosi M. Serial intravascular ultrasonographic measurements after implantation of biodegradable polymer-coated stents in porcine coronary arteries. Coron Artery Dis. 2003;14(5):409-412.
59. Zhang Q, Lu L, Pu L, Zhang R, Shen J, Zhu Z, Hu J, Yang Z, Chen Q, Shen W. Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine. Cardiovasc Diabetol. 2007;6:16.